THRUST AREAS OF RESEARCH
Department of Pharmaceutics
| 1 | Nanosponges |
| 2 | Solid lipid nanoparticles |
| 3 | Micro and nano emulsions |
| 4 | Crystal engineering: Cocrystals and coamorphous systems |
| 5 | Thiomers |
| 6 | Hemostats |
| 7 | Diabetic wound healing |
| 8 | Long acting parenterals |
| 9 | Bigels |
| 10 | Solid dispersions, hydrotropy |
Department of Quality Assurance
| 1 | Analytical method development and validation |
| 2 | Formulation Development |
| 3 | Herbal Standardization |
| 4 | Bioanalytical Method Development and Validation |
| 5 | Validation of Equipments, Processes and Documentation |
Department of Pharmacognosy
| 1 | Standardization of Herbs/Herbal formulations |
| 2 | Formulation of novel herbal formulations |
| 3 | Extraction and isolation of phytochemicals |
Department of Pharmaceutical Chemistry
| 1 | Design and development of potential therapeutic agents using Molecular modelling studies ( 3D QSAR Studies, ADMET Predictions studies, Molecular Docking studies, Molecular dynamic studies, MMGBSA, DFT studies etc) and Artificial Intelligence tools, synthesis and IN-VIVO, IN-VITRO biological evaluation of following therapeutics agents. |
| 2 | Anti cancer agents. |
| 3 | Anti tubercular agents. |
| 4 | Anti viral agents. |
| 5 | Anti diabetic agents. |
| 6 | Antifungal and antibacterial agents. |
| 7 | Cardiovascular Diseases |
| 8 | CNS related activities |
| 9 | Anti-inflammatory, Anti rheumatic agents |
Department of Pharmacology
| 1 | Neuropharmacological research |
| 2 | Gastrointestinal disorders |
| 3 | Inflammatory disorders |
| 4 | Cardiovascular disorders |
| 5 | Diabetes and metabolic disorders |
| 6 | Toxicological evaluations |
| 7 | Reproductive disorders |
| 8 | Drug metabolism and kinetic evaluations |
| 9 | · Autoimmune disorders |